CoChat
Sign Up
Cited by 12

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Querying neXtProt nanopublications and their value for insights on sequence variants and tissue expression

Chichester, Christine, Gaudet, Pascale, Karch, Oliver, Groth, Paul, Lane, Lydie, Bairoch, Amos, Mons, Barend, Loizou, Antonis·2014·Journal of Web Semantics
DOI 10.1016/j.websem.2014.05.001
Open this paper in CoChat — free account

Overview

Integrity signals

Registry

Crossref · 10.1016/j.websem.2014.05.001

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 54

  1. Samwald, 2011, Linked open drug data for pharmaceutical research and development, J. Cheminform., 3, 19, 10.1186/1758-2946-3-19 · DOI
  2. Boncz, 2013, The linked data benchmark council project, Datenbank-Spektrum, 1
  3. A. Loizou, P.T. Groth, On the formulation of performant sparql queries, CoRR 1304.
  4. N.A. Rakhmawati, J. Umbrich, M. Karnstedt, A. Hasnain, M. Hausenblas, Querying over federated sparql endpoints—a state of the art survey, CoRR abs/1306.1723. · arXiv
  5. Patrinos, 2012, Microattribution and nanopublication as means to incentivize the placement of human genome variation data into the public domain, Hum. Mutat., 11, 1503, 10.1002/humu.22144 · DOI
  6. Groth, 2010, The anatomy of a nanopublication, Inform. Serv. Use, 30, 51, 10.3233/ISU-2010-0613 · DOI · Paper page
  7. T. Clark, P. Ciccarese, C. Goble, Micropublications: a semantic model for claims, evidence, arguments and annotations in biomedical communications, CoRR 1305.
  8. A. Callahan, M. Dumontier, Ovopub: modular data publication with minimal provenance, CoRR 1305.
  9. Lane, 2012, nextprot: a knowledge platform for human proteins, Nucleic Acids Res., 40, D76, 10.1093/nar/gkr1179 · DOI
  10. Gaudet, 2013, neXtProt: organizing protein knowledge in the context of human proteome projects, J. Proteome Res., 12, 293, 10.1021/pr300830v · DOI · Paper page
  11. 2011, Ongoing and future developments at the universal protein resource, Nucleic Acids Res., 39, D214, 10.1093/nar/gkq1020 · DOI
  12. C. Chichester, O. Karch, P. Gaudet, L. Lane, B. Mons, A. Bairoch, Converting neXtProt into linked data and nanopublications, (2013), in press.
  13. Searls, 2005, Data integration: challenges for drug discovery, Nat. Rev. Drug Discov., 4, 45, 10.1038/nrd1608 · DOI
  14. Nielsen, 2010, Visualizing genomes: techniques and challenges, Nat. Methods, 7, S5, 10.1038/nmeth.1422 · DOI
  15. Sherry, 2001, dbsnp: the ncbi database of genetic variation, Nucleic Acids Res., 29, 308, 10.1093/nar/29.1.308 · DOI · Paper page
  16. Kent, 2002, The human genome browser at ucsc, Genome Res., 12, 996, 10.1101/gr.229102 · DOI · Paper page
  17. Consortium, 2010, Integrating common and rare genetic variation in diverse human populations, Nature, 467, 52, 10.1038/nature09298 · DOI · Paper page
  18. Thorn, 2013, Pharmgkb: the pharmacogenomics knowledge base, Methods Mol. Biol., 1015, 311, 10.1007/978-1-62703-435-7_20 · DOI
  19. den Dunnen, 2000, Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion, Hum. Mutat., 15, 7, 10.1002/(SICI)1098-1004(200001)15:1<7::AID-HUMU4>3.0.CO;2-N · DOI
  20. den Dunnen, 2001, Nomenclature for the description of human sequence variations, Hum. Mutat., 109, 121
  21. den Dunnen, 2003, Standardizing mutation nomenclature: why bother?, Hum. Mutat., 22, 181, 10.1002/humu.10262 · DOI
  22. 2012, An integrated map of genetic variation from 1092 human genomes, Nature, 491, 56, 10.1038/nature11632 · DOI · Paper page
  23. Ma, 2011, Pharmacogenetics, pharmacogenomics, and individualized medicine, Pharmacol. Rev., 63, 437, 10.1124/pr.110.003533 · DOI
  24. Witze, 2007, Mapping protein post-translational modifications with mass spectrometry, Nat. Methods, 4, 798, 10.1038/nmeth1100 · DOI
  25. Su, 2004, A gene atlas of the mouse and human protein-encoding transcriptomes, Proc. Natl. Acad. Sci. USA, 101, 6062, 10.1073/pnas.0400782101 · DOI · Paper page
  26. Nadeau, 2002, Single nucleotide polymorphisms: tackling complexity, Nature, 420, 517, 10.1038/420517a · DOI
  27. Simmhan, 2005, A survey of data provenance in e-science 2005, SIGMOD Rec., 34, 31, 10.1145/1084805.1084812 · DOI
  28. T. Kuhn, P. Barbano, M. Nagy, M. Krauthammer, Broadening the scope of nanopublications, CoRR 1303.
  29. Ciccarese, 2013, Pav ontology: provenance, authoring and versioning, J. Biomed. Semant., 4, 37, 10.1186/2041-1480-4-37 · DOI
  30. Uhlen, 2010, Towards a knowledge-based human protein atlas, Nat. Biotechnol., 28, 1248, 10.1038/nbt1210-1248 · DOI · Paper page
  31. Bastian, 2001, Bgee: integrating and comparing heterogeneous transcriptome data among species, Lecture Notes in Comput. Sci., 5109, 124, 10.1007/978-3-540-69828-9_12 · DOI
  32. Gremse, 2011, The brenda tissue ontology (bto): the first all-integrating ontology of all organisms for enzyme sources, Nucleic Acids Res., 39, D507, 10.1093/nar/gkq968 · DOI
  33. Forbes, 2011, Cosmic: mining complete cancer genomes in the catalogue of somatic mutations in cancer, Nucleic Acids Res., 39, D945, 10.1093/nar/gkq929 · DOI · Paper page
  34. Sayers, 2011, Database resources of the national center for biotechnology information, Nucleic Acids Res., 15, D38, 10.1093/nar/gkq1172 · DOI
  35. Iakoucheva, 2004, Intrinsic disorder and protein phosphorylation, Nucleic Acids Res., 32, 1037, 10.1093/nar/gkh253 · DOI · Paper page
  36. Obenauer, 2003, Scansite 2.0: Proteome-wide prediction of cell signaling interactions using short sequence motifs, Nucleic Acids Res., 31, 3635, 10.1093/nar/gkg584 · DOI
  37. Blom, 1999, Sequence- and structure-based prediction of eukaryotic protein phosphorylation sites, J. Mol. Biol., 294, 1351, 10.1006/jmbi.1999.3310 · DOI
  38. Wood, 2007, The genomic landscapes of human breast and colorectal cancers, Science, 318, 1108, 10.1126/science.1145720 · DOI · Paper page
  39. Ding, 2008, Somatic mutations affect key pathways in lung adenocarcinoma, Nature, 455, 1069, 10.1038/nature07423 · DOI · Paper page
  40. Jones, 2008, Core signaling pathways in human pancreatic cancers revealed by global genomic analyses, Science, 321, 1801, 10.1126/science.1164368 · DOI · Paper page
  41. Parsons, 2008, An integrated genomic analysis of human glioblastoma multiforme, Science, 321, 1807, 10.1126/science.1164382 · DOI · Paper page
  42. Puente, 2011, Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia, Nature, 475, 101, 10.1038/nature10113 · DOI
  43. Totoki, 2011, High-resolution characterization of a hepatocellular carcinoma genome, Nature, 43, 464
  44. Sjoblom, 2006, The consensus coding sequences of human breast and colorectal cancers, Science, 314, 268, 10.1126/science.1133427 · DOI
  45. Reimand, 2013, Systematic analysis of somatic mutations in phosphorylation signaling predicts novel cancer drivers, Mol. Syst. Biol., 637, S8
  46. Kaminker, 2007, Distinguishing cancer-associated missense mutations from common polymorphisms, Cancer Res., 67, 465, 10.1158/0008-5472.CAN-06-1736 · DOI
  47. N. Rahner, V. Steinke, B. Schlegelberger, F. Eisinger, P. Hutter, S. Olschwang, Clinical utility gene card for: Lynch syndrome (mlh1, msh2, msh6, pms2, epcam) - update 2012, Eur. J. Hum. Genet. 21. · DOI
  48. Petrucelli, 2011, BRCA1 and BRCA2 hereditary breast and ovarian cancer, Gene Rev.
  49. Forbes, 2006, Cosmic 2005, Br. J. Cancer, 94, 318, 10.1038/sj.bjc.6602928 · DOI
  50. Futreal, 2004, A census of human cancer genes, Nat. Rev. Cancer, 4, 177, 10.1038/nrc1299 · DOI · Paper page
  51. Whetzel, 2013, Ncbo technology: powering semantically aware applications, J. Biomed. Semant., 4, S8, 10.1186/2041-1480-4-S1-S8 · DOI
  52. Smith, 2007, The obo foundry: coordinated evolution of ontologies to support biomedical data integration, Nat. Biotechnol., 25, 1251, 10.1038/nbt1346 · DOI
  53. Williams, 2012, Open phacts: semantic interoperability for drug discovery, Drug Discov. Today, 17, 1188, 10.1016/j.drudis.2012.05.016 · DOI · Paper page
  54. Gray, 2012, Applying linked data approaches to pharmacology: architectural decisions and implementation, Semant. Web, 00, 1

Cited by

Sorted by citations

Metadata

Authors
Chichester, C., Gaudet, P., Karch, O., Groth, P., Lane, L., Bairoch, A., Mons, B., & Loizou, A.
Venue
Journal of Web Semantics
Publisher
Elsevier BV
Published
2014-12
Volume
29
Pages
3-11
ISSN
1570-8268
DOI
10.1016/j.websem.2014.05.001
Cited by
12
References
3
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
Innovative Medicines Initiative Joint (115191)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review